The pharmaceutical industry is comprised of organizations that perform scientific research to discover and develop new drugs and market medicines for human and animal health. The industry is based on research and development of medicines that prevent or treat diseases. The Indian pharmaceutical industry is among the top 10 markets globally and generated over $20 billion in revenue last year, expected to reach $26 billion by 2016. It produces drugs for various therapeutic areas and accounts for 1.4% of the global pharmaceutical market, ranking 3rd in production volume and 13th by production size. The market is expected to grow to $55 billion by 2020. India exports drugs to over 200 countries, with the US, EU, and Africa being top importers. Major Indian companies include Sun Ph
2. • The pharmaceutical industry is an important component of health
care systems throughout the world; it is comprised of many public and
private organizations that perform scientific research to discover,
develop new drugs, manufacture and market medicines for human and
animal health.
• The pharmaceutical industry is based primarily upon the scientific
research and development (R&D) of medicines that prevent or treat
diseases and disorders. Most MNP Companies are involved in all
these activities.
Indian pharmaceutical industriesIndian pharmaceutical industries
3. Pharmaceutical Industry is a swiftly growing industry in the
country and India stand among the top 10 pharmaceutical markets in
the world.
The total revenue generated by pharmaceutical companies in
India in the last financial year was more than $20 Billion, which is
expected to cross the mark of $26 Billion by 2016.
It produces drugs and vaccines for various domains like
cardiology, nephrology, neurology, diabetology, Gastroenterology
and Orthopedics etc.
Continue……
4.
5. Global contributionGlobal contribution
• Indian pharmaceutical industry account for about –
1.4 % for the global pharmaceutical industries.
Rank 3 rd in term in the volume of production.
Rank 13 th largest by volume.
6. Trends in Indian Pharmaceutical sector revenue
•The Indian pharmaceuticals market increased at a CAGR of 12.79
% in 2015 from US$ 6 billion in 2005 and expected to expand at a
CAGR of 23.90 % to US$ 55 billion by 2020.
•By 2020, India is likely to be among the top three pharmaceutical
markets by incremental growth and sixth largest market globally in
absolute size.
India - Leading the worldIndia - Leading the world
7. ExportsExports
India exports more than 200 countries all over worlds.
India pharmaceutical exports amt . to USD 15.2 bl in 2014-
2015.
US alone account for around 27 % of total pharmaceutical
export followed by European union and Africa.
8. The Regulatory Control of the Pharmaceutical IndustryThe Regulatory Control of the Pharmaceutical Industry
10. India has the highest number of USFDA approved plants outside
the US
GMP compliant
Approved by international bodies - US FDA and others countries
Manufacturing facilities
Quality Assurance in ManufacturingQuality Assurance in Manufacturing
11. • SUN PHARMACEUTICAL INDUSTRIES LTD - largest pharma- company and
the 5th largest in the world.
• LUPIN - Fastest growing and best pharma-companies. Produces more than
5,500 pharmaceutical products of premier quality.
• DR. REDDY’S LABORATORIES- Presence in more than 20 countries.
• CIPLA- One of the lowest cost manufacturer of anti-HIV drugs.
30 manufacturing plants in world. Produces more than 2,000 products.
• AUROBINDO PHARMA LIMITED- Big pharma-company with 6 manufacturing
units in India and operations in more than120
countries in the world.
Top 10 Pharma- Companies in India in 2015Top 10 Pharma- Companies in India in 2015
12. • CADILA PHARMACEUTICALS LIMITED - Large production
capacity with a production capacity of more than 3,500
Million Tables and over 120 Million Capsules per year.
• GLENMARK - Winner of Best Parma-Company in Emerging
Markets Award
• GLAXOSMITHKLINE- Leads in 6 of the 10 therapeutic categories and
the oldest pharmaceutical companies in India.
• DIVI’S LABORATORIES
• TORRENT PHARMA
13. GlaxoSmithKline Leads in 6 of the 10 therapeutic
categories.
Pfizer Owns the two largest selling
brands in India.
Astra Zeneca Involved in cardiovascular,
respiratory, maternal healthcare
& pain control and anasthesia.
Aventis Indian manufacturing sites identified
as potential global sourcing units
by global parent company.
MNC Presence in IndiaMNC Presence in India
14. Novartis Collaborations with
Dr Reddy’s and Torrent
Wyeth Contract-manufacturing tie-up
with Indian major Bharat Biotech
Sanofi-Synthelabo Present in cardiology,
thrombosis & neuropsychiatry
Rochi Already invested US$ 20 mn in
India and plans additional
US$ 7.35 mn.
Merck Leader in laboratory reagents
market in India
MNC Presence in IndiaMNC Presence in India
15. Novartis AG seeking tie-ups with Indian companies
Bristol-Myers to enter India again
Aventis’s Goa unit to be sourcing hub
Pfizer India doubles research investment in India
AstraZeneca, Glaxo to make India R&D hub
Eli Lilly to make India sourcing hub
India to be Roche's global hub for bulk drugs
MNC Activity in IndiaMNC Activity in India
Indian industry has a story to narrate to the world in almost every sector:
- Hero Honda is the largest manufacturer of motorcycles.
- India`s Pharmaceutical Industry is the 4th largest in the world.
- The country is a global R & D hub. More than a 100 Fortune 500 companies have set up R&D facilities in India.
Indian pharma players are now shifting gears from business-driven research to research-driven business.
- Indian companies are shifting their focus to innovative research - developing non-infringing processes, NDDS, biopharmaceuticals and NCEs.
- Companies like Dr Reddy’s Labs, Ranbaxy and Wockhdart have achieved some early breakthroughs in New Chemical Entities.
- The Glaxo SmithKline-Ranbaxy R&D tie-up for NCE research is the first time a global pharma company has entered into such an alliance with a company in the developing world.
Indian pharma companies are aggressively gearing their manufacturing facilities to international standards.
- India is home to the largest number of pharmaceutical plants approved by the US FDA outside the US - around 70 and the number is rapidly rising.
- Many plants have approval from the UK MCA and the South African MCC.
Domestic players in the Indian pharmaceutical sector are going global.
- Ranbaxy is the largest pharmaceutical company in India, with annual revenues close to US$ 1 bn.
- Globally,it features among the top 10 generic companies and ranks 8th by growth rate.
- Its portfolio includes 28 global brands, available in over 70 countries.
- Dr Reddy's Laboratories Limited has a presence in more than 50 countries with USA, UK, Russia and China as its main markets.
- It was the first Indian company to license an NCE (New Chemical Entity) to an MNC.
- Cipla is one of the lowest cost manufacturers of anti-HIV drugs in the world.
- Its generic version of the AIDS triple cocktail is priced at one-thirtieth its cost in the US.
- Wockhardt does business in over 90 countries and is the largest Indian pharmaceutical company in UK.Its R&D programme rates among the top 3 in India.
Multinational Companies are aggressively leveraging the India advantage:
- GlaxoSmithKline: is the leader in 6 of the 10 therapeutic categories in India.
- Indian operations contribute 7%to GSK`s international revenues.
- Its future plans are bullish on India.
- Astra Zeneca: Astra Zeneca Pharma India Ltd is a part of Astra Zeneca Plc. UK, which ranks among the top 5 pharmaceutical companies in the world.
- Aventis Pharma: is one of the largest pharma MNCS in India.
- Its two manufacturing sites in India have been identified as potential global sourcing units by the global parent company.
- Merck: Merck India is the leader in laboratory reagents market in India.
- The Merck Development Centre (MDC) in India has been making breakthroughs in bulk drugs intermediates.
- Novartis: The project set up by Novartis in India is to result in a saving of USD 42 mn for the company over 5 years.
- Wyeth: Wyeth Lederle has entered into a contract-manufacturing tie-up with Indian major Bharat Biotech.
Many of the global pharma giants have announced ambitious plans for India.
- Parent companies are re-assessing India`s market potential.
- They are increasing stakes in existing ventures, setting up new ventures or entering into tie-ups with local players.
- Novartis AG is seeking tie-ups with Indian companies
- Bristol-Myers is all set to enter India again
- AstraZeneca, Glaxo are set to make India their R&D hub
- Bayer AG and Eli Lilly will make India a sourcing hub
- German major Boehringer Ingelheim is also entering India